Advertisement
Review Article| Volume 33, ISSUE 3, P553-566, September 2013

Download started.

Ok

Molecular Approaches and Biomarkers for Detection of Mycobacterium tuberculosis

  • Robert F. Luo
    Correspondence
    Corresponding author. Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, L235, Stanford, CA 94305.
    Affiliations
    Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, L235, Stanford, CA 94305, USA

    Clinical Microbiology Laboratory, Stanford University Medical Center, 3375 Hillview Avenue, Palo Alto, CA 94304, USA
    Search for articles by this author
  • Niaz Banaei
    Affiliations
    Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, L235, Stanford, CA 94305, USA

    Clinical Microbiology Laboratory, Stanford University Medical Center, 3375 Hillview Avenue, Palo Alto, CA 94304, USA

    Department of Medicine, Stanford University School of Medicine, 300 Pasteur Drive, L134, Stanford, CA 94305, USA
    Search for articles by this author

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • World Health Organization
        Global tuberculosis report.
        World Health Organization, Geneva (Switzerland)2012
        • Steingart K.R.
        • Henry M.
        • Ng V.
        • et al.
        Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review.
        Lancet Infect Dis. 2006; 6: 570-581
        • Hepple P.
        • Ford N.
        • McNerney R.
        Microscopy compared to culture for the diagnosis of tuberculosis in induced sputum samples: a systematic review.
        Int J Tuberc Lung Dis. 2012; 16: 579-588
        • Storla D.G.
        • Yimer S.
        • Bjune G.A.
        A systematic review of delay in the diagnosis and treatment of tuberculosis.
        BMC Public Health. 2008; 8: 15
        • McNerney R.
        • Maeurer M.
        • Abubakar I.
        • et al.
        Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.
        J Infect Dis. 2012; 205: S147-S158
        • Weyer K.
        • Carai S.
        • Nunn P.
        Viewpoint TB diagnostics: what does the world really need?.
        J Infect Dis. 2011; 204: S1196-S1202
        • Greco S.
        • Girardi E.
        • Navarra A.
        • et al.
        Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis.
        Thorax. 2006; 61: 783-790
        • Centers for Disease Control and Prevention
        Nucleic acid amplification tests for tuberculosis.
        MMWR Morb Mortal Wkly Rep. 1996; 45: 950-952
        • Piersimoni C.
        • Callegaro A.
        • Nista D.
        • et al.
        Comparative evaluation of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex in respiratory specimens.
        J Clin Microbiol. 1997; 35: 193-196
        • Guerra R.L.
        • Hooper N.M.
        • Baker J.F.
        • et al.
        Use of the amplified mycobacterium tuberculosis direct test in a public health laboratory: test performance and impact on clinical care.
        Chest. 2007; 132: 946-951
      1. Rapid diagnostic tests for tuberculosis: what is the appropriate use? American Thoracic Society Workshop.
        Am J Respir Crit Care Med. 1997; 155: 1804-1814
        • Centers for Disease Control and Prevention
        Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis.
        MMWR Morb Mortal Wkly Rep. 2009; 58: 7-10
        • McHugh T.D.
        • Pope C.F.
        • Ling C.L.
        • et al.
        Prospective evaluation of BDProbeTec strand displacement amplification (SDA) system for diagnosis of tuberculosis in non-respiratory and respiratory samples.
        J Med Microbiol. 2004; 53: 1215-1219
        • Jouveshomme S.
        • Cambau E.
        • Trystram D.
        • et al.
        Clinical utility of an amplification test based on ligase chain reaction in pulmonary tuberculosis.
        Am J Respir Crit Care Med. 1998; 158: 1096-1101
        • Parsons L.M.
        • Somoskövi A.
        • Gutierrez C.
        • et al.
        Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.
        Clin Microbiol Rev. 2011; 24: 314-350
        • Ling D.I.
        • Flores L.L.
        • Riley L.W.
        • et al.
        Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression.
        PLoS One. 2008; 3: e1536
        • Pai M.
        • Flores L.L.
        • Pai N.
        • et al.
        Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis.
        Lancet Infect Dis. 2003; 3: 633-643
        • Pai M.
        • Flores L.L.
        • Hubbard A.
        • et al.
        Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis.
        BMC Infect Dis. 2004; 4: 6
        • Clinical and Laboratory Standards Institute
        Document EP12–A2. User protocol for evaluation of qualitative test performance.
        CLSI, Wayne (PA)2008
        • Flores L.L.
        • Pai M.
        • Colford J.M.
        • et al.
        In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression.
        BMC Microbiol. 2005; 5: 55
        • Greco S.
        • Rulli M.
        • Girardi E.
        • et al.
        Diagnostic accuracy of in-house PCR for pulmonary tuberculosis in smear-positive patients: meta-analysis and metaregression.
        J Clin Microbiol. 2009; 47: 569-576
        • Luo R.F.
        • Scahill M.D.
        • Banaei N.
        Comparison of single-copy and multicopy real-time PCR targets for detection of Mycobacterium tuberculosis in paraffin-embedded tissue.
        J Clin Microbiol. 2010; 48: 2569-2570
        • Caminero J.A.
        Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding.
        Int J Tuberc Lung Dis. 2010; 14: 382-390
        • World Health Organization
        Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis.
        World Health Organization, Geneva (Switzerland)2008
        • Ignatyeva O.
        • Kontsevaya I.
        • Kovalyov A.
        • et al.
        Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.
        J Clin Microbiol. 2012; 50: 1593-1597
        • Morgan M.
        • Kalantri S.
        • Flores L.
        • et al.
        A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
        BMC Infect Dis. 2005; 5: 62
        • Bwanga F.
        • Hoffner S.
        • Haile M.
        • et al.
        Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis.
        BMC Infect Dis. 2009; 9: 67
        • Ling D.I.
        • Zwerling A.A.
        • Pai M.
        GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis.
        Eur Respir J. 2008; 32: 1165-1174
        • World Health Organization
        Rapid implementation of the Xpert MTB/RIF diagnostic test.
        World Health Organization, Geneva (Switzerland)2011
        • Boehme C.C.
        • Nabeta P.
        • Hillemann D.
        • et al.
        Rapid molecular detection of tuberculosis and rifampin resistance.
        N Engl J Med. 2010; 363: 1005-1015
        • Boehme C.C.
        • Nicol M.P.
        • Nabeta P.
        • et al.
        Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
        Lancet. 2011; 377: 1495-1505
        • Scott L.E.
        • McCarthy K.
        • Gous N.
        • et al.
        Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
        PLoS Med. 2011; 8: e1001061
        • Banada P.P.
        • Sivasubramani S.K.
        • Blakemore R.
        • et al.
        Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.
        J Clin Microbiol. 2010; 48: 3551-3557
        • Andrews J.R.
        • Lawn S.D.
        • Rusu C.
        • et al.
        The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis.
        AIDS. 2012; 26: 987-995
        • Vassall A.
        • van Kampen S.
        • Sohn H.
        • et al.
        Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.
        PLoS Med. 2011; 8: e1001120
        • Boehme C.C.
        • Nabeta P.
        • Henostroza G.
        • et al.
        Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries.
        J Clin Microbiol. 2007; 45: 1936-1940
        • Geojith G.
        • Dhanasekaran S.
        • Chandran S.P.
        • et al.
        Efficacy of loop mediated isothermal amplification (LAMP) assay for the laboratory identification of Mycobacterium tuberculosis isolates in a resource limited setting.
        J Microbiol Methods. 2011; 84: 71-73
        • Mitarai S.
        • Okumura M.
        • Toyota E.
        • et al.
        Evaluation of a simple loop-mediated isothermal amplification test kit for the diagnosis of tuberculosis.
        Int J Tuberc Lung Dis. 2011; 15 (i): 1211-1217
        • Pai N.P.
        • Pai M.
        Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.
        Discov Med. 2012; 13: 35-45
        • Fang X.
        • Chen H.
        • Xu L.
        • et al.
        A portable and integrated nucleic acid amplification microfluidic chip for identifying bacteria.
        Lab Chip. 2012; 12: 1495-1499
        • Köser C.U.
        • Ellington M.J.
        • Cartwright E.J.
        • et al.
        Routine use of microbial whole genome sequencing in diagnostic and public health microbiology.
        PLoS Pathog. 2012; 8: e1002824
        • Gardy J.L.
        • Johnston J.C.
        • Ho Sui S.J.
        • et al.
        Whole-genome sequencing and social-network analysis of a tuberculosis outbreak.
        N Engl J Med. 2011; 364: 730-739
        • Wallis R.S.
        • Pai M.
        • Menzies D.
        • et al.
        Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice.
        Lancet. 2010; 375: 1920-1937
        • Vesenbeckh S.M.
        • Schönfeld N.
        • Mauch H.
        • et al.
        The use of interferon gamma release assays in the diagnosis of active tuberculosis.
        Tuberc Res Treat. 2012; 2012: 768723
        • Metcalfe J.Z.
        • Everett C.K.
        • Steingart K.R.
        • et al.
        Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis.
        J Infect Dis. 2011; 204: S1120-S1129
        • Rangaka M.X.
        • Wilkinson K.A.
        • Glynn J.R.
        • et al.
        Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis.
        Lancet Infect Dis. 2012; 12: 45-55
        • Sester M.
        • Sotgiu G.
        • Lange C.
        • et al.
        Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis.
        Eur Respir J. 2011; 37: 100-111
        • Turtle L.
        • Kemp T.
        • Davies G.R.
        • et al.
        In routine UK hospital practice T-SPOT.TB™ is useful in some patients with a modest pre-test probability of active tuberculosis.
        Eur J Intern Med. 2012; 23: 363-367
        • Steingart K.R.
        • Flores L.L.
        • Dendukuri N.
        • et al.
        Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis.
        PLoS Med. 2011; 8: e1001062
        • World Health Organization
        Commercial serodiagnostic tests for the diagnosis of tuberculosis: policy statement.
        World Health Organization, Geneva (Switzerland)2011
        • Grenier J.
        • Pinto L.
        • Nair D.
        • et al.
        Widespread use of serological tests for tuberculosis: data from 22 high-burden countries.
        Eur Respir J. 2012; 39: 502-505
        • Cannas A.
        • Goletti D.
        • Girardi E.
        • et al.
        Mycobacterium tuberculosis DNA detection in soluble fraction of urine from pulmonary tuberculosis patients.
        Int J Tuberc Lung Dis. 2008; 12: 146-151
        • Chan J.
        • Fan X.D.
        • Hunter S.W.
        • et al.
        Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages.
        Infect Immun. 1991; 59: 1755-1761
        • Minion J.
        • Leung E.
        • Talbot E.
        • et al.
        Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis.
        Eur Respir J. 2011; 38: 1398-1405
        • Lawn S.D.
        • Edwards D.J.
        • Kranzer K.
        • et al.
        Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.
        AIDS. 2009; 23: 1875-1880
        • Lawn S.D.
        • Kerkhoff A.D.
        • Vogt M.
        • et al.
        Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
        Lancet Infect Dis. 2012; 12: 201-209
        • Phillips M.
        • Basa-Dalay V.
        • Bothamley G.
        • et al.
        Breath biomarkers of active pulmonary tuberculosis.
        Tuberculosis (Edinb). 2010; 90: 145-151
        • Kolk A.
        • Hoelscher M.
        • Maboko L.
        • et al.
        Electronic-nose technology using sputum samples in diagnosis of patients with tuberculosis.
        J Clin Microbiol. 2010; 48: 4235-4238
        • Phillips M.
        • Basa-Dalay V.
        • Blais J.
        • et al.
        Point-of-care breath test for biomarkers of active pulmonary tuberculosis.
        Tuberculosis (Edinb). 2012; 92: 314-320
        • Bruins M.
        • Rahim Z.
        • Bos A.
        • et al.
        Diagnosis of active tuberculosis by e-nose analysis of exhaled air.
        Tuberculosis (Edinb). 2012; 93: 232-238
        • Kolk A.H.
        • van Berkel J.J.
        • Claassens M.M.
        • et al.
        Breath analysis as a potential diagnostic tool for tuberculosis.
        Int J Tuberc Lung Dis. 2012; 16: 777-782
        • Qin L.
        • Zheng R.
        • Ma Z.
        • et al.
        The selection and application of ssDNA aptamers against MPT64 protein in Mycobacterium tuberculosis.
        Clin Chem Lab Med. 2009; 47: 405-411
        • Rotherham L.S.
        • Maserumule C.
        • Dheda K.
        • et al.
        Selection and application of ssDNA aptamers to detect active TB from sputum samples.
        PLoS One. 2012; 7: e46862
        • Flores L.L.
        • Steingart K.R.
        • Dendukuri N.
        • et al.
        Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis.
        Clin Vaccine Immunol. 2011; 18: 1616-1627
        • Xie H.
        • Mire J.
        • Kong Y.
        • et al.
        Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe.
        Nat Chem. 2012; 4: 802-809
        • Li H.
        • Yang L.
        • Zheng C.Y.
        • et al.
        Use of bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative pulmonary tuberculosis.
        Int J Tuberc Lung Dis. 2012; 16: 1668-1673
        • Cattamanchi A.
        • Ssewenyana I.
        • Nabatanzi R.
        • et al.
        Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients.
        PLoS One. 2012; 7: e39838
        • Greco S.
        • Girardi E.
        • Masciangelo R.
        • et al.
        Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis.
        Int J Tuberc Lung Dis. 2003; 7: 777-786
        • Jiang J.
        • Shi H.Z.
        • Liang Q.L.
        • et al.
        Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis.
        Chest. 2007; 131: 1133-1141
        • Juan R.S.
        • Sánchez-Suárez C.
        • Rebollo M.J.
        • et al.
        Interferon gamma quantification in cerebrospinal fluid compared with PCR for the diagnosis of tuberculous meningitis.
        J Neurol. 2006; 253: 1323-1330
        • Liang Q.L.
        • Shi H.Z.
        • Wang K.
        • et al.
        Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis.
        Respir Med. 2008; 102: 744-754
        • Xu H.B.
        • Jiang R.H.
        • Li L.
        • et al.
        Diagnostic value of adenosine deaminase in cerebrospinal fluid for tuberculous meningitis: a meta-analysis.
        Int J Tuberc Lung Dis. 2010; 14: 1382-1387
        • Jadhav A.A.
        • Jain A.
        Sputum adenosine deaminase and alkaline phosphatase activity in pulmonary tuberculosis.
        Arch Physiol Biochem. 2012; 118: 6-9
        • Maertzdorf J.
        • Weiner J.
        • Kaufmann S.H.
        Enabling biomarkers for tuberculosis control.
        Int J Tuberc Lung Dis. 2012; 16: 1140-1148
        • Wang C.
        • Yang S.
        • Sun G.
        • et al.
        Comparative miRNA expression profiles in individuals with latent and active tuberculosis.
        PLoS One. 2011; 6: e25832
        • Kumar S.G.
        • Venugopal A.K.
        • Mahadevan A.
        • et al.
        Quantitative proteomics for identifying biomarkers for tuberculous meningitis.
        Clin Proteomics. 2012; 9: 12
        • Fu Y.R.
        • Yi Z.J.
        • Guan S.Z.
        • et al.
        Proteomic analysis of sputum in patients with active pulmonary tuberculosis.
        Clin Microbiol Infect. 2012; 18: 1241-1247
        • Zhang L.
        • Wang Q.
        • Wang W.
        • et al.
        Identification of putative biomarkers for the serodiagnosis of drug-resistant Mycobacterium tuberculosis.
        Proteome Sci. 2012; 10: 12